SHOWCASE VIDEO

A conversation with Rob Davidson, CEO of Cure Pharmaceutical and Nancy Duitch, founder and CEO of Sera Labs 

Cure Pharmaceutical (OTC: CURR) has entered into a memorandum of understanding to acquire privately-held Sera Labs.

About Cure Pharmaceutical 

Cure Pharmaceutical® is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug forms and delivery systems, including for cannabinoids such as CBD.

Cure Pharmaceutical recently announced that the company intended to acquire Sera Labs, a leader in the CBD industry with proprietary products and a multi-channel distribution platform. Nancy Duitch is the founder and CEO of Sera Labs. (To view the news release click here.)

​

For more information regarding CURE Pharmaceutical, or if you have any questions, please visit the company's website at www.curepharma.com or contact:

Company Contact:

Gary Zwetchenbaum 

Plum Tree Consulting LLC

Tel 516 455 7662

Email gzplumtree@gmail.com

The company description has been approved by CURE Pharmaceutical. Please view Medical and Pharma Insider's disclosure and disclaimer here. 

Medical and Pharma Insider videos provide an opportunity for you to view video interviews with the management of medical, healthcare, pharma, and companies.  

​

These interviews include management of start-up, early-stage, growing, middle-market companies, and subsidiaries or divisions of major companies, including both privately-held and publicly-traded companies.

Objectives of our featured companies typically include:

​

• Exposure for products, services, research, or development activities
• Obtaining strategic partners for research, development or distribution
• Obtaining industry financial partners
• Providing updates to current and potential shareholders
• Using it to provide the equivalent of a "video news release" to discuss recent company developments.